COMMUNIQUÉS West-GlobeNewswire

GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease Program at 23rd European Hematology Association (EHA) Congress

17/05/2018 - 16:30

SOUTH SAN FRANCISCO, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that data supporting its voxelotor program in sickle cell disease (SCD) will be [...]

Genmab Announces Abstracts to be Presented at 23rd EHA Annual Congress

17/05/2018 - 16:19

Media Release Seven industry sponsored abstracts regarding Genmab programs scheduled for presentation at EHA Annual Congress Two oral presentations, five poster presentations Copenhagen, Denmark; May 17, 2018 – Genmab A [...]

Active Biotech AB Interim report January - March 2018

17/05/2018 - 16:01

First quarter in brief Decision on new share issue with preferential rights for shareholders taken at Extraordinary General Meeting on March 19, 2018 Patent application for tasquinimod for the treatment of multiple [...]

NanoVibronix Provides Business Update for the First Quarter 2018

17/05/2018 - 15:44

ELMSFORD, N.Y., May 17, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV ) , a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today [...]

FIT Biotech Oy: FIT Biotech Ltd's own equity negative in the end of April - FIT Biotech Ltds' equity will be positive with draw down of the fourth tranche

17/05/2018 - 15:31

FIT Biotech Oy Company release May 17, 2018 at 4:30 pm EET FIT Biotech Ltd's own equity negative in the end of April - FIT Biotech Ltds' equity will be positive with draw down of the fourth tranche The Company's own [...]

Healthcare Administrative Technology Association (HATA) Puts Forth Bold Recommendations Regarding NCVHS Predictability Roadmap

17/05/2018 - 15:30

Association calls for business needs and ROI validation, an emerging trend monitoring organization, standard transaction usage requirements, and data harmonization LAGUNA BEACH, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- [...]

Abattis Signs Agreement with Cannamedix to Support the Development and Commercialization of CBD-infused Natural Health Products

17/05/2018 - 15:28

VANCOUVER, British Columbia, May 17, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) is pleased to announce it has entered into a non-binding letter of intent ( [...]

Bellicum Announces Clinical Presentations on Lead Product Candidate BPX-501 at the 23rd Congress of the European Hematology Association

17/05/2018 - 15:20

Oral and poster presentations highlight BPX-501 data in pediatric patients with PIDs and AML HOUSTON, May 17, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM ), a leader in developing novel, [...]

Abeona Reports Update from EB-101 Gene Therapy in Epidermolysis Bullosa at 21st Annual ASGCT Meeting

17/05/2018 - 15:20

Phase 1/2 Study Update Confirms EB-101 is Safe and Well-tolerated, with Durable Efficacy NEW YORK and CLEVELAND, May 17, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage [...]

Olainfarm Sales In The First 4 Month Face 8% Increase

17/05/2018 - 15:17

Olainfarm Sales In The First 4 Month Face 8% Increase Consolidated Results April and 4 Months of 2018 Preliminary consolidated results of JSC Olainfarm for April 2018 show that Groups’ sales in April reached 11,03 [...]

UPDATE: PotNetwork Holdings’ Diamond CBD Giving Away 25,000 Assorted Gummy Bear Samples at CHAMPS Atlantic City 2018

17/05/2018 - 15:14

Set to Make a Dominating Impact Through the Mass Circulation of Diamond CBD’s Increasingly Popular Edibles, the Company Gives Away Samples of one of its Fastest Growing Product Lines to Vendors at the World’s Most [...]

Epizyme to Present New Tazemetostat Data at the American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) Congress

17/05/2018 - 15:13

Company to Host Investor Conference Call Today at 9:30 a.m. EDT CAMBRIDGE, Mass., May 17, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage company developing novel epigenetic therapies, announced [...]

TG Therapeutics, Inc. Announces Upcoming Data Presentations at the 54th Annual Meeting of the American Society of Clinical Oncology and the 23rd Congress of the European Hematology Association

17/05/2018 - 15:10

NEW YORK, May 17, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ), today announced that abstracts featuring umbralisib (TGR-1202), the Company's once-daily PI3K delta inhibitor, and TG-1701, the Company’s [...]

Geron Announces Oral Presentation at European Hematology Association Congress

17/05/2018 - 15:05

Updated Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes to be Presented MENLO PARK, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN ) today announced that an abstract [...]

HempAmericana Begins Bottling and Distribution Phase for 99% Pure CBD Isolate Production

17/05/2018 - 15:03

NEW YORK, May 17, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce that it is in the final testing stage of specialized bottling [...]

Novartis data at ASCO and EHA reinforce company's commitment to reimagining cancer

17/05/2018 - 15:00

Results from the Kisqali ® MONALEESA clinical trial program, the largest industry- sponsored Phase III registration program researching a CDK4/6 inhibitor in HR+/HER2- advanced breast cancer, will be presented at ASCO [...]

Ceapro Inc. Reports 2018 First Quarter Results

17/05/2018 - 15:00

EDMONTON, Alberta, May 17, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO ) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for [...]

Atara Biotherapeutics to Present Long-Term Tab-cel™ Phase 2 Clinical Outcomes for Patients with Epstein-Barr Virus Associated Post-Transplant Lymphomas at 23rd Congress of European Hematology Association

17/05/2018 - 15:00

SOUTH SAN FRANCISCO, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]

Trading by management and close relations of management

17/05/2018 - 14:54

Read the full announcement in the attached file Attachment 2018_34_Trading_by_management_EN